Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.
Where this comes from
- Record sourced from PubMed, PMID 27254277.
- Also identified by DOI 10.1371/journal.pone.0157094 and PMC identifier 4890937.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0137834.].